Sex: U
Vaccine: DTAPIPV, FLU4, HEP, HEPA, MNQ, TDAP, VARZOS
Symptoms: Product storage error
Clinical narrative: temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received Flu Seasonal QIV Quebec (FluLaval Tetra 2020-2021 season) (batch number E9R44, expiry date unknown), (batch number 47K47, expiry date 30th June 2022) and (batch number 2578B, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) (batch number MR5RK, expiry date unknown) and (batch number GC5NG, expiry date 1st April 2023) for prophylaxis, DTPa-IPV (Kinrix) (batch number E2L254, expiry date 3rd March 2023) for prophylaxis, dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis, Men ACWY-CRM NVS (Menveo) (batch number AMVA468A, expiry date unknown), (batch number AMVA584A, expiry date 31st August 2022) and (batch number AMVA575A, expiry date 31st July 2022) for prophylaxis, HBV (Engerix B) (batch number 77X473, expiry date 22nd December 2023) for prophylaxis, Herpes zoster (Shingrix) (batch number 4C493, expiry date unknown) and (batch number 4B244, expiry date unknown) for prophylaxis, HAV (Havrix) (batch number YR532, expiry date 9th September 2022) and (batch number 2K57N, expiry date 11th December 2022) for prophylaxis and hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received FluLaval Tetra 2020-2021 season. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the patient started Flulaval Tetra Pre-Filled Syringe Device and Boostrix. On an unknown date, the dose was an unknown dose. On an unknown date, the patient received Kinrix, Kinrix Pre-Filled Syringe Device and Menveo. On an unknown date, the dose was an unknown dose. On an unknown date, the dose was an unknown dose. On an unknown date, the patient received Engerix B and Shingrix. On an unknown date, the dose was an unknown dose. On an unknown date, the patient received Havrix. On an unknown date, the dose was an unknown dose. On an unknown date, the patient started Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving FluLaval Tetra 2020-2021 season, Flulaval Tetra Pre-Filled Syringe Device, Boostrix, Kinrix, Kinrix Pre-Filled Syringe Device, Menveo, Engerix B, Shingrix, Havrix and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination were not applicable. The reporter reported that several GlaxoSmithKline vaccines were part of a temperature excursion twice  The reporter reported that Flulaval QIV, Boostrix, Menveo, Kinrix, Havrix, Shingrix, Engerix B were part of 2 excursions but reporter declined to receive stability data as reporter knew they should be discarded, they just wanted to know how to proceed with 68 patients (no data available at the moment) that received vaccinations after temperature excursion.  No data on patients, only information available was that 68 patients were vaccinated.  HCP provided Lot number and expiration dates for some of the vaccines. The reporter consented to follow up.